了解结核病药物发现的关键挑战:未来会发生什么?
Rima Zein-Eddine1, Masoud Ramuz2, Guislaine Refrégier3
1Laboratoire d'Optique et Biosciences (LOB), Ecole Polytechnique, Inserm U1182, CNRS UMR7645, Institut Polytechnique de Paris, Palaiseau, France.
Expert opinion on drug discovery
|July 12, 2025
概括
结核病 (TB) 耐药性是一个日益严重的问题,需要新的治疗方法. 人工智能 (AI) 在加速发现新型结核病药物方面表现有前途,但仍然存在挑战.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 由Mycobacterium tuberculosis (Mtb) 引起的结核病 (TB) 是一个严重的全球卫生问题,死亡率高.
- 药物耐药性的增加,特别是多药耐药结核病 (MDR-TB),导致治疗结果不佳.
- Mtb的弹性细胞壁和缓慢生长需要长时间的治疗方案,通常对抗性菌株无效.
研究的目的:
- 审查当前的结核病治疗策略和耐药性演变.
- 识别Mtb药物发现中的挑战和新兴方法.
- 探索下一代战略,包括人工智能驱动的药物开发.
主要方法:
- 关于Mtb耐药性和治疗策略的综合文献综述.
- 对针对MTB的药物发现新兴趋势的分析.
- 评估AI在加速临床前候选药物鉴定中的作用.
主要成果:
- 由于耐药性和Mtb的生物特征,现有的结核病治疗面临挑战.
- 人工智能在发现安全和生物可用的临床前结核病候选药物方面显示出潜力.
- 数据的局限性和生物复杂性对人工智能驱动的结核病药物发现构成挑战.
结论:
- 迫切需要新的,短期,负担得起的,结合友好的药物来治疗结核病.
- 人工智能为加速结核病药物发现提供了一个有希望的途径.
- 未来的进步需要多模式的人工智能模型,开放数据和跨学科的合作.
相关概念视频
Pulmonary Tuberculosis V
243
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
243
Pulmonary Tuberculosis IV
207
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
207
Pulmonary Tuberculosis II
378
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
378
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Pulmonary Tuberculosis I
330
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
330
Pulmonary Tuberculosis III
448
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
448


